Cargando…

LILRB4, an immune checkpoint on myeloid cells

Leukocyte immunoglobulin-like receptor B4 (LILRB4) is an inhibitory receptor in the LILR family mainly expressed on normal and malignant human cells of myeloid origin. By binding to ligands, LILRB4 is activated and subsequently recruits adaptors to cytoplasmic immunoreceptor tyrosine inhibitory moti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Ting, Qian, Yixin, Liang, Xiaoting, Wu, Jianbo, Zou, Ming, Deng, Mi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362873/ https://www.ncbi.nlm.nih.gov/pubmed/35957669 http://dx.doi.org/10.1097/BS9.0000000000000109

Ejemplares similares

LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation
por: Yeboah, Muchaala, et al.
Publicado: (2020)

Molecular regulatory mechanism of LILRB4 in the immune response
por: LIU, Haiyin, et al.
Publicado: (2023)

Pan-cancer analysis reveals distinct clinical, genomic, and immunological features of the LILRB immune checkpoint family in acute myeloid leukemia
por: Xu, Zi-jun, et al.
Publicado: (2022)

Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer
por: Zeller, Tobias, et al.
Publicado: (2023)

LILRB4 signaling in leukemia cells mediates T cell suppression and tumor infiltration
por: Deng, Mi, et al.
Publicado: (2018)

NK cells require immune checkpoint receptor LILRB4/gp49B to control neurotropic Zika virus infections in mice
por: Lee, Ha-Na, et al.
Publicado: (2022)

LILRB3 suppresses immunity in glioma and is associated with poor prognosis
por: Zhuang, Qiyuan, et al.
Publicado: (2023)

LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy
por: Sharma, Naveen, et al.
Publicado: (2021)

281 Fc gamma receptor crosslinking promotes antibody-induced LILRB4 internalization and immune regulation of acute monocytic leukemia
por: Morse, Joshua, et al.
Publicado: (2023)

The impact of HLA-G, LILRB1 and LILRB2 gene polymorphisms on susceptibility to and severity of endometriosis
por: Bylińska, Aleksandra, et al.
Publicado: (2017)

The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection
por: Brown, Damien P, et al.
Publicado: (2009)

ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells
por: Liu, Xiaoye, et al.
Publicado: (2015)

LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2–cFLIP–NF-κB signaling axis
por: Wu, Guojin, et al.
Publicado: (2021)

Structures of the four Ig-like domain LILRB2 and the four-domain LILRB1 and HLA-G1 complex
por: Wang, Qihui, et al.
Publicado: (2019)

LILRB2-containing small extracellular vesicles from glioblastoma promote tumor progression by promoting the formation and expansion of myeloid-derived suppressor cells
por: Wu, Peitao, et al.
Publicado: (2023)

KIR, LILRB and their Ligands’ Genes as Potential Biomarkers in Recurrent Implantation Failure
por: Nowak, Izabela, et al.
Publicado: (2017)

Elevated LILRB1 expression predicts poor prognosis and is associated with tumor immune infiltration in patients with glioma
por: Zou, Renheng, et al.
Publicado: (2023)

Expression of the innate immune receptor LILRB5 on monocytes is associated with mycobacteria exposure
por: Hogan, Louise E., et al.
Publicado: (2016)

Correction to: LILRB2-containing small extracellular vesicles from glioblastoma promote tumor progression by promoting the formation and expansion of myeloid-derived suppressor cells
por: Wu, Peitao, et al.
Publicado: (2023)

Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells
por: Chen, Heyu, et al.
Publicado: (2020)

Antibody-Mediated LILRB2-Receptor Antagonism Induces Human Myeloid-Derived Suppressor Cells to Kill Mycobacterium tuberculosis
por: Singh, Vipul K., et al.
Publicado: (2022)

Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages
por: Zeller, Tobias, et al.
Publicado: (2022)

Characterization of the Leucocyte Immunoglobulin-like Receptor B4 (Lilrb4) Expression in Microglia
por: Kretzschmar, Felix, et al.
Publicado: (2021)

LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions
por: Zhao, Peng, et al.
Publicado: (2022)

LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis
por: Li, Dan-Pei, et al.
Publicado: (2023)

HLA-G, LILRB1 and LILRB2 Variants in Zika Virus Transmission from Mother to Child in a Population from South and Southeast of Brazil
por: de Moraes, Amarilis Giaretta, et al.
Publicado: (2022)

Targeting Immune Signaling Checkpoints in Acute Myeloid Leukemia
por: Giannopoulos, Krzysztof
Publicado: (2019)

Structural basis for RIFIN-mediated activation of LILRB1 in malaria
por: Harrison, Thomas E., et al.
Publicado: (2020)

Prognostic impact of LILRB4 expression on tumor‐infiltrating cells in resected non‐small cell lung cancer
por: Kumata, Sakiko, et al.
Publicado: (2023)

LILRA3 Binds Both Classical and Non-Classical HLA Class I Molecules but with Reduced Affinities Compared to LILRB1/LILRB2: Structural Evidence
por: Ryu, Myongchol, et al.
Publicado: (2011)

LILRB4 Decrease on uDCs Exacerbate Abnormal Pregnancy Outcomes Following Toxoplasma gondii Infection
por: Zhan, Shaowei, et al.
Publicado: (2018)

New Targets for Antiviral Therapy: Inhibitory Receptors and Immune Checkpoints on Myeloid Cells
por: Liu, Yanni, et al.
Publicado: (2022)

Unveiling T cell evasion mechanisms to immune checkpoint inhibitors in acute myeloid leukemia
por: Gurska, Lindsay, et al.
Publicado: (2023)

Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Abaza, Yasmin, et al.
Publicado: (2022)

Structural basis of malaria RIFIN binding by LILRB1-containing antibodies
por: Chen, Yiwei, et al.
Publicado: (2021)

HLA-F and LILRB1 Genetic Polymorphisms Associated with Alloimmunisation in Sickle Cell Disease
por: Bernit, Emmanuelle, et al.
Publicado: (2023)

Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade
por: Peranzoni, Elisa, et al.
Publicado: (2020)

Decidual Macrophage Functional Polarization during Abnormal Pregnancy due to Toxoplasma gondii: Role for LILRB4
por: Li, Zhidan, et al.
Publicado: (2017)

Expression patterns of immune checkpoints in acute myeloid leukemia
por: Chen, Cunte, et al.
Publicado: (2020)

A common missense variant of LILRB5 is associated with statin intolerance and myalgia
por: K Siddiqui, Moneeza, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c00i437sbm7aepghg7n8ef6i6e